Study of treatment choices for untreated brain cavernous malformations
Part of Blood & lymphatic, Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation clinical trials.
This study looks at how to best treat people with untreated cerebral cavernous malformations (a cluster of abnormal blood vessels in the brain). It compares outcomes between those who have surgery and those who are monitored with regular check-ups, and will follow participants for a long time to see how they do.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a cerebral cavernous malformation (CCM) on an MRI scan.
- You have not had any surgery, radiation, or other invasive treatments for this condition before.
- You are willing to have long-term follow-up appointments and tests.
- If you have surgery, you agree to let researchers study a small piece of the removed tissue.
- If you choose observation only, you agree to let researchers use your imaging data for research.
- You do not have other serious brain conditions (like aneurysms or tumors) or severe medical illnesses that would limit your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI scans to measure brain changes in people whose seizures are related to one cerebral cavernous malformation (a type of abnormal blood vessel in the brain). It aims to find a measurable “biomarker” from MRI that may help understand the epilepsy and the brain structure around it.
This study collects medical and imaging information from people with a brain arteriovenous malformation (AVM) to understand how different treatments are used in real life. It may help doctors improve future care, even if you are not receiving a new drug in this study.
This study looks at outcomes for people with an unruptured brain arteriovenous malformation (AVM) using medical care only, without procedures. It may help doctors understand which medical approach and monitoring works best for different AVM locations seen on CT scans.
This study uses MRI scans to look at how the brain's waste-clearing system (glymphatic function) and white matter are affected in people with cerebral venous disorders (either narrowing or blood clots in the brain's veins). It aims to improve understanding of these conditions, which may lead to better treatments.
This study tests a medication called daratumumab to see if it is safe and helps people with familial cerebral cavernous malformations (CCM). The drug is given as an infusion and may slow down or prevent new bleeding or symptoms from these brain blood vessel clusters.
This study follows people with a hereditary form of cavernous malformations (clusters of abnormal blood vessels in the brain). It aims to understand how the condition changes over time, without testing any new treatments.
Hear when a new Hemangioma, Cavernous, Central Nervous System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.